Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1

NCT02705534 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C
Cirrhosis

Interventions

DRUG: Sofosbuvir
DRUG: Ledipasvir
DRUG: Ribavirin

Sponsor

Tehran University of Medical Sciences

Collaborators

[object Object]